AHR
American Healthcare REIT, Inc.
AHR's fundamentals are strong: revenue grew 24% and earnings per share more than tripled. Its PE isn't a useful guide right now because of how its recent earnings were reported.
AHR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AHR's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for real estate companies like AHR.
AHR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 72x | $58.64 | — |
| Cheap | 79x | $39.41 | -33% |
| Fair | 113x | $56.28 | -4% |
| Current | 117x | $58.64 | — |
| Expensive | 400x | $200 | +241% |
Historical ranges are pointers, not guarantees.
AHR's PE is 117x, but its earnings don't support one, so it isn't a reliable read right now.
AHR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for AHR, with profitability holding steady.
AHR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.81 | +62% |
| Q3 2026 | $0.50 | +317% |
| Q2 2026 | $0.69 | +$0.93 |
| Q1 2026 | $0.59 | +$0.88 |
| Q4 2025 | $0.42 | +$0.71 |
| Q3 2025 | $0.12 | +$0.59 |
| Q2 2025 | -$0.24 | +$0.29 |
| Q1 2025 | -$0.29 | +$0.44 |
| Q4 2024 | -$0.29 | +$0.79 |
AHR's earnings per share have climbed steadily: $0.50 over the past year, about four times what it earned the year before, and higher year over year for 11 quarters in a row.
AHR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $742.1M | +30% |
| Q2 2026 | $674.3M | +24% |
| Q1 2026 | $650.8M | +20% |
| Q4 2025 | $604.1M | +22% |
| Q3 2025 | $572.9M | +20% |
| Q2 2025 | $542.5M | +18% |
| Q1 2025 | $540.6M | +8.2% |
| Q4 2024 | $496.8M | +15% |
AHR's revenue has grown year over year for 15 quarters in a row: $742M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +3.7 points |
| Q2 2026 | 20% | +1.3 points |
| Q1 2026 | 19% | +1.8 points |
| Q4 2025 | 18% | -1.5 points |
| Q3 2025 | 18% | -1.2 points |
| Q2 2025 | 19% | -0.3 points |
| Q1 2025 | 17% | +1 points |
| Q4 2024 | 20% | +0.4 points |
AHR's operating margin was 22% last quarter, up 3.7 points from the same quarter a year ago.
AHR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $166.9M | +56% |
| Q2 2026 | $118.6M | +66% |
| Q1 2026 | $81.1M | +34% |
| Q4 2025 | $55.2M | -7.3% |
| Q3 2025 | $107.2M | +70% |
| Q2 2025 | $71.5M | +20% |
| Q1 2025 | $60.6M | +$66.6M |
| Q3 2024 | $63.1M | +117% |
AHR's free cash flow was $422M over the past year, up 41% from the year before. Free cash flow isn't a meaningful measure for real estate companies like AHR.
AHR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.9x | Moderate |
AHR's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.4 years a year ago. Net leverage isn't a meaningful measure for real estate companies like AHR.
AHR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 78.2 | Neutral |
AHR's weekly RSI is 65 (neutral) and its Stochastic is 78 (neutral).
AHR PE vs Real Estate Sector
| Metric | AHR | Sector median | Relative |
|---|---|---|---|
| PE | 117x | 24x | 391% above |
| PE % | 59 | 8 | 51 pts above |
AHR is trading at 117x earnings, a 391% premium to the Real Estate sector's median of 24x, though its earnings don't support one.
AHR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $53.7 | 9.1% above |
| 20 week MA | $54.6 | 7.4% above |
| 50 week MA | $51.3 | 14% above |
| 100 week MA | $43.6 | 34% above |
AHR is in an uptrend: it's above all four of its weekly moving averages, and 34% above its 100-week average.
AHR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.1 | $28.5 | +117% |
| 2025 | $28.5 | $48.0 | +68% |
| 2026 YTD | $48.0 | $58.6 | +22% |
AHR has finished every year since 2024 higher, and it's up 22% so far in 2026.